{
  "id": 3767615,
  "title": "Revolution pancreatic cancer drug should quickly become a blockbuster, analysts say",
  "url": "https://urgent.news/2026/08/27/revolution-pancreatic-cancer-drug-should-quickly-become-a-blockbuster",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-27T15:30:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/revolution-rasonque-price-pancreatic-cancer-drug-launch-sales/828918/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Rasonque’s $39,800 monthly list price surpassed Wall Street forecasts and led to rosier sales projections ahead of what one analyst described as a “historic” launch.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}